700
Helvetica Chimica Acta ± Vol. 83 (2000)
signals could be noticed. 13C-NMR2): 67.92 (d, C(1)); 28.51 (t, C(2)); 116.27 (s, C(3)); 65.46 (d, C(4)); 33.04
(t, C(5)); 42.78 (d, C(6)); 132.40 (s, C(7)); 90.80 (s, C(8)); 89.19 (s, C(9)); 104.76 (d, C(10)); 149.74 (s, C(11));
24.92 (q, C(12)); 132.12 (d, C(3')); 121.16 (t, C(7')); 21.22 (q, C(11')); 170.02 (s, MeCOO C(4)); 167.71
.
(s, MeCOO C(3')); 20.70 (q, MeCOO C(4)); 21.31 (q, MeCOO C(3')). EI-MS: 332 (2, M ), 290 (1, [M
.
.
.
CH2CO] ), 272 (1.5, [M CH3COOH] ), 230 (7.5, [M CH2CO CH3COOH] ), 212 (9), 201 (7), 183
(10), 169 (7), 43 (100).
4. Cyclizations of ()-(R)-Citronellal (8). 4.1. With ZnBr2. To a soln. of 8 (30.0 mg, 0.19 mmol) in CH2Cl2
(4 ml), ZnBr2 (1 equiv.) was added at r.t. and stirring was continued for 30 min until all 8 had disappeared (TLC
monitoring). Precipitated ZnBr2 was filtered off and the eluate evaporated: 9/10 9 :1, as established by
integration of 1H-NMR signals [10].
4.2. With EtAlCl2. The reagents were mixed as described in 4.1., except for using EtAlCl2 as Lewis acid.
After a few minutes, complete conversion of 8 to 9/10 7 :3 was observed.
5. Alkaline Hydrolysis of 3 and 5. 5.1. To a soln. of 3 (2.3 mg, 0.007 mmol) in MeOH (2 ml), solid K2CO3
was added. Complete conversion of 3 to volvatellin (4a) was observed (TLC monitoring) within a few minutes.
The mixture was passed through a strong anion-exchanger (Merck LiChrolut SAX (500 mg), H2O (elimination
of salts), then MeOH): 4a (2.1 mg, 90%). HPLC (hexane/AcOEt 96 :4, flow 1 ml min 1; l 230 nm) gave
(4R,5S)-5-hydroxy-4-(5-methyl-1-methylenehex-4-en-2-ynyl)cyclohex-1-ene-1-carbaldehyde (4a; tR 9.2) of high
20
purity for polarimetric measurements. [a]2D0 7, [a] 43 (c 0.1, CHCl3) ([3]: [a]D
88.3 (c 0.04,
577
1
Et2O)). H-NMR and low-resolution MS: in accordance with [3]. HR-MS: 230.1302 Æ 0.002 (C15H18O2 ; calc.
230.1307).
5.2. On addition of solid K2CO3 to a soln. of 3 or 5 (2 mg) in CD3OD (0.6 ml) in a NMR tube, clean and
complete formation of 4a or the diastereoisomeric aldehyde 7, respectively, was observed. 1H-NMR (CD3OD;
only the most relevant spectral differences are reported2): 3.90 (dt, J 5.5, 9.1, H C(1) (4a)); 4.40 (dt, J 3.6,
2.6, H C(1) (7)); 6.88 (m, H C(4) (4a)); 6.97 (m, H C(4) (7)); 2.47 (dt, J 5.8, 9.5, H C(6) (4a)); 2.39
(dt, J 2.0, 3.8, H C(6) (7)); 5.35, 5.38 (2 br. s, 2 H C(7') (4a)); 5.37, 5.45 (2 br. s, 2 H C(7') (7)).
6. Acetylation of 4a. Aldehyde 4a (1.8 mg, 0.008 mmol) was treated with excess Ac2O in dry pyridine
(0.5 ml) under stirring at r.t. overnight. Then a sat. aq. CuSO4 soln. (1 ml) and AcOEt (1 ml) were added, and
the mixture was passed through a Whatman phase-separation filter. The org. phase was evaporated and
subjected to prep. TLC (hexane/AcOEt 7:3): pure 4b (2.0, 94%). [a]2D0 15, [a]577 54 (c 0.1, CHCl3)
([3]: [a]D
57.2 (c 0.08, CHCl3). 1H-NMR: in accordance with [3].
7. Synthesis of the MTPA Esters 6a and 6b. Compound 3 (5 mg; 0.015 mmol) was treated with ( )-(R)-
MTPA-Cl (3 mol-equiv.) and 4-(dimethylamino)pyridine (1.0 mg) in dry pyridine (0.5 ml) under stirring for
24 h at r.t. The mixture was then quenched with sat. aq. CuSO4 soln. (1 ml), followed by Et2O (4 ml), and passed
through a Whatman phase-separation filter. The org. phase was evaporated and subjected to prep. TLC (hexane/
AcOEt 7:3): 6a (7.3 mg, 88%). By a similar procedure, the same amounts of 3 and ()-(S)-MTPA-Cl gave 6b
(7.4 mg, 88%). NMR and TLC examination of the crude reaction mixtures showed that both 6a and 6b were
obtained as single diastereoisomers.
(aS)-a-Methoxy-a-(trifluoromethyl)benzeneacetic Acid (1S,2R,4S,5Z)-4-(Acetyloxy)-5-[(acetyloxy)methy-
lene]-2-(5-methyl-1-methylenehex-4-en-2-ynyl)cyclohexyl Ester (6a). 1H-NMR2): 5.10 (td, J 10.7, 4.8,
H
H
C(1)); 2.25 (ddd, J 2.3, 10.7, 13.1, Hax C(2)); 2.60 (dd, J 4.8, 13.1, Heq C(2)); 5.92 (t, J 2.8,
C(4)); 1.85 (ddd, J 2.8, 12.8, 14.8, Hax C(5)); 2.05 (ddd, J 2.8, 3.8, 14.8, Heq C(5)); 2.85 (ddd, J 3.8,
10.7, 12.8, H C(6)); 5.37 (sept., J 1.3, H C(10)); 1.86 (s, 3 H C(12)); 7.06 (d, J 2.0, H C(3')); 5.33, 5.30
(2d, J 1.8, 2 H C(7')); 1.81 (s, 3 J 11')); 2.04 (s, AcO C(4)); 2.17 (s, AcO C(3')); 7.50 (m, 2 arom. H); 7.38
(m, 3 arom. H); 3.54 (q, 5J(H,F) 1.1, MeO). 13C-NMR2): 75.68 (d, C(1)); 30.56 (t, C(2)); 116.91 (s, C(3));
64.52 (d, C(4)); 35.11 (t, C(5)); 44.49 (d, C(6)); 132.64 (s, C(7)); 90.30 (s, C(8)); 88.09 (s, C(9)); 104.74
(d, C(10)); 149.80 (s, C(11)); 24.95 (q, C(12)); 132.67 (d, C(3')); 122.65 (t, C(7')); 21.24 (q, C(11')); 169.86
(s, MeCOO C(4)); 167.67 (s, MeCOO C(3')); 20.66 (q, MeCOO C(4)); 21.24 (q, MeCOO C(3')); 165.79
(s, ROCO C(1)); 84.60 (q, 2J(C,F) 28, CCO C(1)); 123.12 (q, 1J(C,F) 288, CF3); 55.72 (s, MeO); 127.30
.
(d, 2 arom. C); 128.28 (d, 2 arom. C); 129.52 (d, arom. C); 129.65 (s, arom. C). EI-MS: 548 (8, M ), 506 (3),
488 (3), 229 (7), 213 (15), 212 (40), 77 (12), 43 (100).
(aR)-a-Methoxy-a-(trifluoromethyl)benzeneacetic Acid (1S,2R,4S,5Z)-4-(Acetyloxy)-5-[(acetyloxy)methy-
lene]-2-(5-methyl-1-methylenehex-4-en-2-ynyl)cyclohexyl Ester (6b). 1H-NMR2): 5.13 (td, J 10.7, 4.8,
H
H
C(1)); 2.45 (ddd, J 2.2, 11.2, 13.1, Hax C(2)); 2.63 (dd, J 4.8, 13.1, Heq C(2)); 5.93 (t, J 2.8,
C(4)); 1.85 (ddd, J 2.8, 12.6, 15.0, Hax C(5)); 2.04 (ddd, J 2.8, 3.9, 15.0, Heq C(5)); 2.82 (ddd, J 3.9,
10.7, 12.6, H C(6)); 5.38 (sept., J 1.3, H C(10)); 1.89 (s, 3 H C(12)); 7.07 (d, J 2.1, H C(3')); 5.08, 5.07
(2d, J 1.7, 2 H C(7')); 1.82 (s, 3 H C(11')); 2.07 (s, AcO C(4)); 2.17 (s, AcO C(3')); 7.50, 7.38 (2m,